Evidence map›Paper›PMID 30634643›Full record

ArticlePharmaceutics2019

Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells.

Olga A Krasheninina, Evgeny K Apartsin, Elena Fuentes, Aleksandra Szulc, Maksim Ionov, Alya G Venyaminova, Dzmitry Shcharbin, F Javier de la Mata, Maria Bryszewska, Rafael Gόmez

Abstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Supramolecular Self-Associations of Amphiphilic Dendrons and Their Properties.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Review
  13. Article
  14. Article
  15. Silver (I)Pharmaceutics · 2020
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olga A KrashenininaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia. okrasheninina@gmail.com.ORCID 0000-0001-7317-6232
Evgeny K ApartsinInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia. eka@niboch.nsc.ru.ORCID 0000-0003-3334-0397
Elena FuentesDepartamento de Química Orgánica y Química Inorgánica, UAH-IQAR, Universidad de Alcalá, 28805 Alcalá de Henares, Spain. elena.fuentes.paniagua@gmail.com.
Aleksandra SzulcDepartment of General Biophysics, University of Lodz, 90-236 Lodz, Poland. aleksandra_szulc@interia.pl.
Maksim IonovDepartment of General Biophysics, University of Lodz, 90-236 Lodz, Poland. maksion@biol.uni.lodz.pl.ORCID 0000-0001-7227-6864
Alya G VenyaminovaInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia. ven@niboch.nsc.ru.
Dzmitry ShcharbinInstitute of Biophysics and Cell Engineering of NASB, 220072 Minsk, Belarus. d.shcharbin@gmail.com.ORCID 0000-0002-1414-4465
F Javier de la MataDepartamento de Química Orgánica y Química Inorgánica, UAH-IQAR, Universidad de Alcalá, 28805 Alcalá de Henares, Spain. javier.delamata@uah.es.
Maria BryszewskaDepartment of General Biophysics, University of Lodz, 90-236 Lodz, Poland. marbrys@biol.uni.lodz.pl.
Rafael GόmezDepartamento de Química Orgánica y Química Inorgánica, UAH-IQAR, Universidad de Alcalá, 28805 Alcalá de Henares, Spain. rafael.gomez@uah.es.

Funding

Foundation for assistance to small innovative enterprises 3649GU1/2014Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III IMMUNOTHERCAN-CM (B2017/BMD3733)Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III NANODENDMED-II-CM (B2017/BMD-3703)Ministerio de Economía y Competitividad CTQ-2017-85224-PRussian Foundation for Basic Research 16-33-60152Russian Foundation for Basic Research 18-33-20109Scholarship of the President of the Russian Federation 1778.2015.4Scholarship of the President of the Russian Federation 882.2016.4Seventh Framework Programme PIRSES-GA-2012-316730 NANOGENE
6 · The paper itself

Abstract

This paper examines the complexation of anti-cancer small interfering RNAs (siRNAs) by cationic carbosilane dendrimers, and the interaction of the formed complexes with HeLa and HL-60 cancer cells. Stepwise formation of the complexes accompanied by the evolution of their properties has been observed through the increase of the charge ratio (dendrimer/siRNA). The complexes decrease the viability of both "easy-to-transfect" cells (HeLa) and "hard-to transfect" ones (HL-60), indicating a high potential of the cationic carbosilane dendrimers for siRNA delivery into tumor cells.

Indexed as

anticancer siRNAbiophysical assayscarbosilanecomplexationcytotoxicitydendrimersdendriplexesnucleic acidstransfection

Identifiers

PMID30634643
PMCPMC6359069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.